HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sandra Lassalle Selected Research

Indicators and Reagents (Reagents)

12/2021Evaluation of Sample Pooling for SARS-CoV-2 Detection in Nasopharyngeal Swab and Saliva Samples with the Idylla SARS-CoV-2 Test.
12/2016PD-L1 expression in basaloid squamous cell lung carcinoma: Relationship to PD-1+ and CD8+ tumor-infiltrating T cells and outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sandra Lassalle Research Topics

Disease

20Neoplasms (Cancer)
04/2022 - 09/2007
7Melanoma (Melanoma, Malignant)
12/2021 - 05/2015
6Papillary Thyroid Cancer
05/2014 - 11/2009
5Thyroid Neoplasms (Thyroid Cancer)
05/2016 - 06/2006
4Lung Neoplasms (Lung Cancer)
02/2019 - 04/2016
4Adenocarcinoma of Lung
01/2019 - 02/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 01/2018
2Uveal melanoma
12/2021 - 01/2021
2Neoplasm Metastasis (Metastasis)
12/2021 - 01/2021
2COVID-19
12/2021 - 12/2020
1Immune Reconstitution Inflammatory Syndrome
05/2021
1Thyroid Diseases (Thyroid Disease)
01/2021
1Margins of Excision
01/2019
1Pleural Effusion (Pleural Effusions)
01/2018
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
12/2016
1Hypoxia (Hypoxemia)
09/2013
1Colonic Neoplasms (Colon Cancer)
02/2013
1Follicular Adenocarcinoma
10/2011
1Hyperplasia
11/2009
1Carcinoma (Carcinomatosis)
11/2009
1Crohn Disease (Crohn's Disease)
06/2009
1Hand-Foot Syndrome
07/2008
1Gram-Negative Bacterial Infections
09/2007
1Gastritis
06/2007
1Tuberculosis (Tuberculoses)
12/2006
1Granuloma
12/2006
1Acquired Immunodeficiency Syndrome (AIDS)
12/2006
1HIV Infections (HIV Infection)
09/2005
1Lipodystrophy
09/2005

Drug/Important Bio-Agent (IBA)

7Biomarkers (Surrogate Marker)IBA
12/2021 - 03/2018
6Biological ProductsIBA
11/2021 - 10/2010
4Immune Checkpoint InhibitorsIBA
01/2021 - 12/2016
4Formaldehyde (Formol)FDA Link
11/2017 - 12/2006
3DNA (Deoxyribonucleic Acid)IBA
06/2018 - 12/2006
3ParaffinIBA
11/2017 - 12/2006
3MicroRNAs (MicroRNA)IBA
05/2016 - 10/2011
2Hematoxylin (Haematoxylon)IBA
03/2022 - 12/2006
2Eosine Yellowish-(YS) (Eosin)IBA
03/2022 - 12/2006
2Indicators and Reagents (Reagents)IBA
12/2021 - 12/2016
2Monoclonal AntibodiesIBA
12/2016 - 05/2015
2Proteins (Proteins, Gene)FDA Link
09/2013 - 01/2010
2Uridine Monophosphate (UMP)IBA
10/2011 - 07/2009
1RNA (Ribonucleic Acid)IBA
01/2021
1Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2019
1Tyrosine Kinase InhibitorsIBA
01/2019
1pembrolizumabIBA
01/2018
1N 30IBA
01/2018
1Mitogen-Activated Protein KinasesIBA
05/2015
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2015
1Carbonic Anhydrase IXIBA
09/2013
1Tissue Inhibitor of Metalloproteinase-1IBA
09/2013
1Lactalbumin (alpha-Lactalbumin)IBA
12/2011
1VorinostatFDA Link
12/2011
1Etoposide (VP 16)FDA LinkGeneric
12/2011
1Histones (Histone)IBA
12/2011
1trichostatin A (A 300)IBA
12/2011
1Histone Deacetylase InhibitorsIBA
12/2011
1RacivirIBA
10/2011
1Fixatives (Pickling Agents)IBA
11/2009
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2009
1Capecitabine (Xeloda)FDA Link
07/2008
1Toll-Like Receptors (Toll-Like Receptor)IBA
09/2007
1Pharmaceutical PreparationsIBA
06/2007

Therapy/Procedure

8Therapeutics
04/2022 - 09/2005
5Immunotherapy
12/2021 - 04/2016
3Highly Active Antiretroviral Therapy (HAART)
05/2021 - 09/2005
1Organ Transplantation
05/2021
1Precision Medicine
01/2021
1Proton Therapy
12/2019
1Cryotherapy (Therapy, Cold)
12/2019
1Molecular Targeted Therapy
02/2019
1Drug Therapy (Chemotherapy)
01/2019
1Lasers (Laser)
12/2006
1Thyroidectomy
06/2006